Stay updated on Optimized Nivolumab Management Clinical Trial
Sign up to get notified when there's something new on the Optimized Nivolumab Management Clinical Trial page.

Latest updates to the Optimized Nivolumab Management Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe changes consist of date and revision metadata updates (e.g., new and removed dates and revision labels) with no impact on core study information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check19 days agoChange DetectedThe page shows a minor site version update from v3.4.0 to v3.4.1; no substantive changes to study details, eligibility criteria, or user-facing content are detected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check41 days agoChange DetectedA new revision label 'Revision: v3.3.4' is shown, replacing the previous 'Revision: v3.3.3'.SummaryDifference0.0%

- Check62 days agoChange DetectedAdded study locations: California, Illinois, Massachusetts, North Carolina, Rhode Island, Utah, and Wisconsin, and updated the Locations section. The revision version moved from v3.3.2 to v3.3.3.SummaryDifference0.7%

- Check91 days agoChange DetectedAdded a note that publications are automatically filled from PubMed and may not all pertain to the study, and updated the revision tag to v3.3.2.SummaryDifference0.1%

- Check98 days agoChange DetectedThe funding lapse notice on the page has been removed. The previous notice warned that information may not be up to date and directed users to NIH CC status and opm.gov for updates.SummaryDifference0.3%

Stay in the know with updates to Optimized Nivolumab Management Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Optimized Nivolumab Management Clinical Trial page.